Multiple G1 regulatory elements control the androgen-dependent proliferation of prostatic carcinoma cells (Q47761529)

5 February 2018

title

Multiple G1 regulatory elements control the androgen-dependent proliferation of prostatic carcinoma cells (English)

1 reference

5 February 2018

author name string

Knudsen KE

series ordinal

1

1 reference

5 February 2018

Arden KC

series ordinal

2

1 reference

5 February 2018

Cavenee WK

series ordinal

3

1 reference

5 February 2018

language of work or name

English

0 references

publication date

1 August 1998

1 reference

5 February 2018

Journal of Biological Chemistry

published in

1 reference

5 February 2018

volume

273

1 reference

5 February 2018

issue

32

1 reference

5 February 2018

page(s)

20213-20222

1 reference

5 February 2018

Role of programmed (apoptotic) cell death during the progression and therapy for prostate cancer

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.32.20213

Review of the role of androgenic hormones in the epidemiology of benign prostatic hyperplasia and prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.32.20213

Functional domains of the human androgen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.32.20213

G1 events and regulation of cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.32.20213

G1 phase progression: cycling on cue

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.32.20213

Cyclin-dependent protein kinases: key regulators of the eukaryotic cell cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.32.20213

Principles of CDK regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.32.20213

Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.32.20213

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.32.20213

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.32.20213

Cyclin A-associated kinase activity is rate limiting for entrance into S phase and is negatively regulated in G1 by p27Kip1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.32.20213

Inhibitors of mammalian G1 cyclin-dependent kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.32.20213

Activity of the retinoblastoma family proteins, pRB, p107, and p130, during cellular proliferation and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.32.20213

Cellular targets for activation by the E2F1 transcription factor include DNA synthesis- and G1/S-regulatory genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.32.20213

Cyclin D1 is dispensable for G1 control in retinoblastoma gene-deficient cells independently of cdk4 activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.32.20213

Altered cell cycle kinetics, gene expression, and G1 restriction point regulation in Rb-deficient fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.32.20213

Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.32.20213

Hormonal regulation of prostate-specific antigen (PSA) glycoprotein in the human prostatic adenocarcinoma cell line, LNCaP

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.32.20213

The androgen receptor in LNCaP cells contains a mutation in the ligand binding domain which affects steroid binding characteristics and response to antiandrogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.32.20213

Dual Mechanisms for the Inhibition of E2F Binding to RB by Cyclin-Dependent Kinase-Mediated RB Phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.32.20213

Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.32.20213

Cyclin-dependent regulation of G1 in mammalian fibroblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.32.20213

Abrogation of retinoblastoma protein function by c-Abl through tyrosine kinase-dependent and -independent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.32.20213

p34cdc2 kinase activity is maintained upon activation of the replication checkpoint in Schizosaccharomyces pombe

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.32.20213

New functional activities for the p21 family of CDK inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.32.20213

Androgenic and antiandrogenic control on epidermal growth factor, epidermal growth factor receptor, and androgen receptor expression in human prostate cancer cell line LNCaP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.32.20213

Identification of a growth suppression domain within the retinoblastoma gene product

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.32.20213

Differential regulation of retinoblastoma protein function by specific Cdk phosphorylation sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.32.20213

SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.32.20213

Regulation of the cell cycle by viral oncoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.32.20213

A conserved HPD sequence of the J-domain is necessary for YDJ1 stimulation of Hsp70 ATPase activity at a site distinct from substrate binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.32.20213

Inactivation of pRB-related proteins p130 and p107 mediated by the J domain of simian virus 40 large T antigen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.32.20213

Regulation of the cyclin-dependent kinase inhibitor p27 by degradation and phosphorylation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.32.20213

Cyclin E and c-Myc promote cell proliferation in the presence of p16INK4a and of hypophosphorylated retinoblastoma family proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.32.20213

Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.32.20213

Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.32.20213

Cyclin D1 as a cellular proto-oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.32.20213

Cyclin D1 induction in breast cancer cells shortens G1 and is sufficient for cells arrested in G1 to complete the cell cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.32.20213

Prostate cancer in a transgenic mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.32.20213

p53, bcl-2 and retinoblastoma proteins as long-term prognostic markers in localized carcinoma of the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.32.20213

Loss of the retinoblastoma susceptibility gene (RB1) is a frequent and early event in prostatic tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.32.20213

Allelic loss of chromosomes 16q and 10q in human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.32.20213

21 January 2018

Identifiers

DOI

10.1074/JBC.273.32.20213

1 reference

5 February 2018

1 reference

5 February 2018